SEC Form SC 13G/A filed by Entera Bio Ltd. (Amendment)
$ENTX
Biotechnology: Biological Products (No Diagnostic Substances)
Health Care
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 3)*
Entera Bio Ltd.
(Name of Issuer)
Ordinary Shares, par value NIS 0.0000769 per share
(Title of Class of Securities)
M40527109
(CUSIP Number)
December 31, 2021
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☒ Rule 13d-1(c)
☐ Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
CUSIP No. M40527109
|
13G | Page 2 of 7 Pages |
|
1
|
NAME OF REPORTING PERSONS
Capital Point Ltd.
|
||||
|
2
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See instructions)
(a) ☐
(b) ☒
|
||||
|
3
|
SEC USE ONLY
|
||||
|
4
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Israel
|
||||
|
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH
|
5
|
SOLE VOTING POWER
0
|
|||
|
6
|
SHARED VOTING POWER
---
|
||||
|
7
|
SOLE DISPOSITIVE POWER
0
|
||||
|
8
|
SHARED DISPOSITIVE POWER
---
|
||||
|
9
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
|
||||
|
10
|
CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (See instructions)
☐
|
||||
|
11
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.00%
|
||||
|
12
|
TYPE OF REPORTING PERSON (See instructions)
CO
|
||||
2
| Item 1. (a) |
Name of Issuer:
|
Entera Bio Ltd.
| (b) |
Address of Issuer's Principal Executive Offices:
|
Kiryat Hadassah, Minrav Building – Fifth Floor
Jerusalem 9112002, Israel
| Item 2. (a) |
Name of Person Filing:
|
Capital Point Ltd.
| (b) |
Address of Principal Business Office:
|
Azrieli 1, Tel Aviv 67021, Israel
| (c) |
Citizenship:
|
Israel
| (d) |
Title of Class of Securities:
|
Ordinary Shares, par value NIS 0.0000769
|
(e)
|
CUSIP Number:
|
M40527109
| Item 3. |
Not applicable.
|
| Item 4. |
Ownership:
|
| (a) |
Amount beneficially owned:
|
See row 9 of cover page
3
|
(b)
|
Percent of class:
|
See row 11 of cover page
| (c) |
Number of shares as to which such person has:
|
|
(i)
|
Sole power to vote or to direct the vote:
See row 5 of cover page
|
|
(ii)
|
Shared power to vote or to direct the vote:
See row 6 of cover page
|
|
(iii)
|
Sole power to dispose or to direct the disposition of:
See row 7 of cover page
|
|
(iv)
|
Shared power to dispose or to direct the disposition of:
See row 8 of cover page
|
| Item 5. |
Ownership of Five Percent or Less of a Class:
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the
beneficial owner of more than 5 percent of the class of securities, check the following ☒.
| Item 6. |
Ownership of More than Five Percent on Behalf of Another:
|
Not applicable.
4
| Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person:
|
Not applicable.
| Item 8. |
Identification and Classification of Members of the Group:
|
Not applicable.
| Item 9. |
Notice of Dissolution of Group:
|
Not applicable.
5
| Item 10. |
Certification:
|
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not
acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that
purpose or effect.
6
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
February 14, 2022
|
Capital Point Ltd.
By:
/s/ Shay Lior Name: Shay Lior Title: Co-Chief Executive Officer
|
|
/s/ Yossi Tamar Name: Yossi Tamar Title: Co-Chief Executive Officer
|
7